| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| Cambridge Equities, LP | 66% | -3.8% | $4,406,356,855 | +$9,487,063 | 745,576,456 | +0.22% | Patrick Soon-Shiong | 23 Feb 2026 |
As of 31 Dec 2025, 260 institutional investors reported holding 167,490,288 shares of ImmunityBio, Inc. - Common Stock, par value $0.0001 per share (IBRX). This represents 15% of the company’s total 1,124,549,707 outstanding shares.
The largest institutional shareholders of ImmunityBio, Inc. - Common Stock, par value $0.0001 per share (IBRX) together control 13% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| VANGUARD GROUP INC | 2.9% | 32,777,257 | +19% | 0% | $64,898,969 |
| BlackRock, Inc. | 2.3% | 25,601,219 | +29% | 0% | $50,690,414 |
| STATE STREET CORP | 1.5% | 16,455,703 | +45% | 0% | $32,582,292 |
| JANE STREET GROUP, LLC | 1.3% | 14,224,224 | +11% | 0.03% | $28,163,963 |
| GEODE CAPITAL MANAGEMENT, LLC | 0.7% | 7,920,178 | +15% | 0% | $15,684,103 |
| GOLDMAN SACHS GROUP INC | 0.55% | 6,152,684 | +439% | 0% | $12,182,314 |
| MORGAN STANLEY | 0.45% | 5,106,214 | +51% | 0% | $10,110,303 |
| TWO SIGMA INVESTMENTS, LP | 0.42% | 4,717,843 | +81% | 0.01% | $9,341,329 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 0.32% | 3,654,499 | +38% | 0.01% | $7,235,908 |
| Woodline Partners LP | 0.31% | 3,446,540 | -35% | 0.03% | $6,824,149 |
| AlphaCore Capital LLC | 0.27% | 3,000,544 | +0.4% | 0.13% | $5,941,077 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 0.22% | 2,501,666 | +8.8% | 0% | $4,953,299 |
| BARCLAYS PLC | 0.22% | 2,444,163 | +163% | 0% | $4,839,444 |
| BANK OF AMERICA CORP /DE/ | 0.21% | 2,382,503 | +44% | 0% | $4,717,356 |
| TANG CAPITAL MANAGEMENT LLC | 0.21% | 2,333,333 | 0% | 0.23% | $4,619,999 |
| NORTHERN TRUST CORP | 0.2% | 2,230,112 | +11% | 0% | $4,415,622 |
| UBS Group AG | 0.18% | 1,995,607 | +19% | 0% | $3,951,301 |
| Voleon Capital Management LP | 0.13% | 1,514,586 | +9218% | 0.06% | $2,998,880 |
| Squarepoint Ops LLC | 0.13% | 1,494,713 | +48% | 0.01% | $2,959,532 |
| Skandinaviska Enskilda Banken AB (publ) | 0.12% | 1,324,871 | 0% | 0.01% | $2,616,620 |
| RENAISSANCE TECHNOLOGIES LLC | 0.11% | 1,231,770 | +21% | 0% | $2,438,905 |
| JPMORGAN CHASE & CO | 0.11% | 1,219,879 | +15% | 0% | $2,415,361 |
| TWO SIGMA ADVISERS, LP | 0.1% | 1,142,256 | +871% | 0% | $2,261,667 |
| Bank of New York Mellon Corp | 0.08% | 882,327 | +16% | 0% | $1,747,007 |
| Clearwater Capital Advisors, LLC | 0.08% | 845,084 | -0.16% | 0.14% | $1,673,267 |
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2025 Q4 | 167,490,288 | $331,608,857 | +$45,291,330 | $1.98 | 260 |
| 2025 Q3 | 149,650,186 | $368,148,509 | +$61,432,781 | $2.46 | 258 |
| 2025 Q2 | 124,100,473 | $327,790,828 | +$117,120,227 | $2.64 | 236 |
| 2025 Q1 | 79,547,067 | $239,251,849 | -$5,452,987 | $3.01 | 205 |
| 2024 Q4 | 82,639,855 | $211,622,425 | +$33,803,467 | $2.56 | 193 |
| 2024 Q3 | 68,558,924 | $255,147,599 | +$21,750,911 | $3.72 | 172 |
| 2024 Q2 | 61,630,296 | $389,584,078 | -$21,451,973 | $6.32 | 188 |
| 2024 Q1 | 66,215,691 | $355,583,288 | +$50,300,460 | $5.37 | 157 |
| 2023 Q4 | 57,525,605 | $288,814,721 | +$55,491,609 | $5.02 | 141 |
| 2023 Q3 | 49,844,823 | $84,098,555 | +$17,530,681 | $1.69 | 128 |
| 2023 Q2 | 38,816,393 | $107,856,591 | -$8,601,646 | $2.78 | 108 |
| 2023 Q1 | 46,154,939 | $83,993,343 | -$34,886,181 | $1.82 | 141 |
| 2022 Q4 | 49,991,144 | $253,404,020 | +$54,026,855 | $5.07 | 134 |
| 2022 Q3 | 39,497,245 | $196,456,912 | +$32,509,458 | $4.97 | 117 |
| 2022 Q2 | 33,071,782 | $123,053,543 | -$11,174,770 | $3.72 | 124 |
| 2022 Q1 | 35,583,839 | $199,726,649 | +$5,888,206 | $5.61 | 135 |
| 2021 Q4 | 34,419,957 | $209,314,595 | +$13,197,046 | $6.08 | 127 |
| 2021 Q3 | 31,920,475 | $310,877,791 | +$41,850,403 | $9.74 | 118 |
| 2021 Q2 | 27,315,269 | $390,084,556 | +$155,924,275 | $14.28 | 115 |
| 2021 Q1 | 15,930,587 | $378,240,945 | +$377,213,945 | $23.74 | 112 |
| 2020 Q4 | 100 | $1,000 | $10.00 | 1 | |
| 2020 Q3 | 100 | $1,000 | $10.00 | 1 | |
| 2020 Q2 | 100 | $1,000 | $10.00 | 1 | |
| 2020 Q1 | 100 | $1,000 | $10.00 | 1 | |
| 2019 Q4 | 100 | $1,000 | $10.00 | 1 | |
| 2019 Q3 | 100 | $1,000 | $10.00 | 1 | |
| 2019 Q2 | 100 | $1,000 | $10.00 | 1 | |
| 2019 Q1 | 100 | $1,000 | $10.00 | 1 |